FHIR © HL7.org  |  Server Home  |  XIG Home  |  XIG Stats  |  Server Source  |  FHIR  

FHIR IG Statistics: FHIR Resources

ValueSets

29,056 resources

Source: Text:

By Version

By Authority

By Realm

 

Start Prev Rows 22600 - 22800 Next

PackageVersionIdentityName/TitleStatusFMMWGDateRealmAuthSource(s)
hl7.terminologyR5v3-HealthCareCommonProcedureCodingSystemHealthCareCommonProcedureCodingSystemactive2023-10uvhl7cms
hl7.fhir.uv.genomics-reportingR4hgnc-vsHUGO Gene Nomenclature Committee Gene Names (HGNC)trial-use2cg2025-06uvhl7gene
tw.gov.mohw.nhi.ngsR4hgnc-vsHUGO Gene Nomenclature Committee Gene Names (HGNC)active2024-12twnationalgene
hl7.fhir.vn.coreR4observation-codesLOINC Codesdraft1fhir2019-10vnhl7loinc
fhir.deep6.aiR4deep-6-ai-location-typeDeep 6 AI Location Type Value Setactive2023-08ushl7internal tho
fhir.deep6.aiR4deep-6-ai-location-physical-typeDeep 6 AI Location Physical Type Value Setactive2023-11ushl7internal fhir
de.medizininformatikinitiative.use-case.omiR4body-siteSNOMED CT Body Structuresdraft1oo2019-10desct
hl7.fhir.uv.extensionsR5time-duration-unitsCommon UCUM Codes for Time Durationtrial-use1fhir2025-05uvhl7ucum
ca.infoway.io.pscaR4substanceandpharmaceuticalbiologicproductcodeSubstance And Pharmaceutical/Biologic Product Codedraft1899-12canational
ca.infoway.vc.psR4substanceandpharmaceuticalbiologicproductcodeSubstance And Pharmaceutical/Biologic Product Codedraft2021-12canational
PHCDIR4DrugCodesVSDrug Codesdraft2025-06
example.fhir.ph.coreR4drugsDrugsdraft2025-06
hl7.fhir.cz.imgR4cz-composition-type-vsCZ Composition Typedraft2025-08czhl7sct
hl7.fhir.cz.img-orderR4cz-composition-type-vsCZ Composition Typedraft2025-08czhl7sct
hl7.fhir.eu.imaging-manifest-r5R5im-procedure-typeImaging Procedure Typedraft2025-07euhl7sct
hl7.fhir.eu.imaging-r5R5im-procedure-typeImaging Procedure Typedraft2025-08euhl7sct
hl7.fhir.cz.imgR4cz-procedure-typeCZ Procedure Typedraft2025-08czhl7sct
hl7.fhir.cz.imgR4cz-observationCode-vsCZ Observation codedraft2025-08czhl7sct
hl7.fhir.uv.extensions.r3R3mimetypesMime Typesnormative5fhir2023-03uvhl7ietf
ihe.pharm.mpd.r4R4substance-codesSNOMED CT Substance Codesdraft1brruvihesct
hl7.fhir.us.qicoreR4qicore-medication-dose-typeQICore SNOMED CT Dosage Codestrial-use4cqi2018-08ushl7sct
hl7.fhir.us.insurance-cardR4C4DICContactTypeVSC4DIC Contact Typeactiveclaims2024-04ushl7fhir tho
hl7.fhir.us.insurance-cardR4C4DICCopayTypeVSC4DIC Copay Typeactiveclaims2024-04ushl7fhir
hl7.fhir.us.insurance-cardR4C4DICCoverageClassVSC4DIC Coverage Classactiveclaims2024-04ushl7fhir tho
hl7.terminologyR5consent-verificationConsent Verification Codesactive2cbcc2024-04uvhl7tho
lung.ca.screen.assignmentR4SCLC_StagesSCLC-stagedraft
ndhm.inR4ndhm-productorserviceProductorServicedraft2022-07innationalsct
hl7.terminologyR5subscriber-relationshipSubscriberPolicyholder Relationship Codesactive2fm2024-04uvhl7tho
signal.core.r4R4subscriber-relationshipSubscriberPolicyholder Relationship Codestrial-use2fm2019-10ushl7tho
smart.who.int.trust-phwR4DVCVaccinesDVC - Vaccinesdraft2025-08uvwho
smart.who.int.icvpR4ICVPVaccineCodesICVP - Vaccine Codesdraft2025-07who
ndhm.inR4ndhm-encounter-typeEncounterTypesdraft2022-06innationalsct
hl7.fhir.eu.epsR4medical-devices-snomed-absent-unknown-eu-hdrMedical Devices - SNOMED CT + Absent/Unknown - IPSdraft12025-06euhl7internal fhir
hl7.fhir.eu.hdrR4medical-devices-snomed-absent-unknown-eu-hdrMedical Devices - SNOMED CT + Absent/Unknown - IPSdraft12025-06euhl7internal fhir
HIE2.packagesR4medication-snomed-uv-ipsMedications (SNOMED CT) - IPSactive2022-01uvhl7sct
hl7.fhir.eu.epsR4medical-devices-eu-hdrMedical Devices (SNOMED CT)draft12025-06euhl7sct
hl7.fhir.eu.hdrR4medical-devices-eu-hdrMedical Devices (SNOMED CT)draft12025-06euhl7sct
hl7.fhir.eu.hdrR4procedures-snomed-absent-unknown-eu-hdrProcedures - SNOMED CT + Absent/Unknown - IPSdraft12025-06euhl7fhir sct
hl7.fhir.eu.hdrR4procedure-snomed-eu-hdrProcedure codes: Snomed CTdraft12025-06euhl7sct
ihe.pharm.mpd.r4R4medicinal-product-classificationProduct Classificationdraft1brruviheatc
hl7.fhir.us.pacio-pfeR4pfe-category-vsPersonal Functioning and Engagement Category Value Settrial-use3pc2025-07ushl7fhir
hl7.fhir.uv.ae-research-backport-igR4adverse-event-type-vsAdverseEvent Typeinformativebrr2024-04uvhl7sct
hl7.fhir.uv.ae-research-backport-igR4adverse-event-mitigating-action-vsAdverseEvent Mitigating Actioninformativebrr2024-04uvhl7sct
hl7.fhir.uv.ae-research-backport-igR4adverse-event-seriousness-non-only-vsAdverseEvent Seriousness Non-serious Codes Onlyinformativebrr2024-04uvhl7tho
hl7.fhir.uv.ae-research-backport-igR4adverse-event-contributing-factor-vsAdverseEvent Contributing Factorinformativebrr2024-04uvhl7sct
hl7.fhir.uv.ae-research-backport-igR4adverse-event-supporting-infoAdverseEvent Supporting Informationinformativebrr2024-04uvhl7sct
hl7.fhir.uv.ae-research-backport-igR4adverse-event-participant-function-vsAdverse Event Participant Functionsinformativebrr2024-04uvhl7tho
hl7.terminologyR5adverse-event-clinical-research-outcomesAdverse Event Clinical Research Outcomesactive1brr2023-07uvhl7ncit
hl7.fhir.uv.phrR4pcd-sleep-observation-codePatient contributed data: sleep observation codeinformativepe2025-06uvhl7sct loinc
StandardPatientHealthRecordIGR4pcd-sleep-observation-codePatient contributed data: sleep observation codedraft2023-09sct loinc
hl7.fhir.uv.phrR4pcd-sleep-observation-valuePatient contributed data: sleep stage valueinformativepe2025-06uvhl7sct
StandardPatientHealthRecordIGR4pcd-sleep-observation-valuePatient contributed data: sleep stage valuedraft2023-09sct
hl7.fhir.us.carin-rtpbcR4rtpbc-prescribable-product-codeRTPBC Prescribable Product Code Value Settrial-use4phx2020-05ushl7rx ndc
signal.core.r4R4languagesCommon Languagesdraft5fm2016-08ushl7ietf
ee.hl7.fhir.base.r4R4eebase-actencountercodeEEBase ActEncounterCodedraft2022-09hl7tho
hl7.terminologyR5ex-diagnosisrelatedgroupExample Diagnosis Related Group Codesactive1fm2024-04uvhl7tho
hl7.terminologyR5ex-diagnosistypeExample Diagnosis Type Codesactive1fm2024-04uvhl7tho
hl7.terminologyR5ex-diagnosis-on-admissionExample Diagnosis on Admission Codesactive1fm2024-04uvhl7tho
hl7.terminologyR5ex-paymenttypeExample Payment Type Codesactive1fm2024-04uvhl7tho
hl7.terminologyR5ex-procedure-typeExample Procedure Type Codesactive1fm2024-04uvhl7tho
hl7.terminologyR5ex-benefitcategoryBenefit Category Codesactive1fm2024-04uvhl7tho
us.cdc.phinvadsR42.16.840.1.114222.4.11.3204Non-Laboratory Intervention and Procedureactive2009-01ussct
hl7.terminologyR5claim-subtypeExample Claim SubType Codesactive1fm2024-04uvhl7tho
hl7.terminologyR5consent-actionConsent Action Codesactive1cbcc2024-04uvhl7tho
hl7.terminologyR5contract-actionContract Action Codesactive1fm2024-04uvhl7tho
hl7.terminologyR5contract-actorroleContract Actor Role Codesactive1fm2024-04uvhl7tho
hl7.terminologyR5contract-signer-typeContract Signer Type Codesactivefm2024-04uvhl7tho
hl7.terminologyR5contract-subtypeContract Subtype Codesactive1fm2024-04uvhl7tho
hl7.terminologyR5contract-term-subtypeContract Term Subtype Codesactive1fm2024-04uvhl7tho
hl7.terminologyR5contract-term-typeContract Term Type Codesactive1fm2024-04uvhl7tho
hl7.terminologyR5contract-typeContract Type Codesactive1fm2024-04uvhl7tho
hl7.terminologyR5coverage-copay-typeCoverage Copay Type Codesactive2fm2024-04uvhl7tho
signal.core.r4R4coverage-copay-typeCoverage Copay Type Codestrial-use2fm2019-10ushl7tho
hl7.terminologyR5claim-exceptionException Codesactive1fm2024-04uvhl7tho
hl7.terminologyR5claim-informationcategoryClaim Information Category Codesactive1fm2024-04uvhl7tho
hl7.terminologyR5missing-tooth-reasonMissing Tooth Reason Codesactive1fm2024-04uvhl7tho
hl7.terminologyR5claim-modifiersModifier type Codesactive1fm2024-04uvhl7tho
hl7.terminologyR5payment-typePayment Type Codesactive1fm2024-04uvhl7tho
hl7.terminologyR5ex-program-codeExample Program Reason Codesactive1fm2024-04uvhl7tho
hl7.terminologyR5provider-qualificationExample Provider Qualification Codesactive1fm2024-04uvhl7tho
hl7.terminologyR5consent-policyConsent PolicyRule Codesactive2cbcc2024-04uvhl7tho
hl7.terminologyR5related-claim-relationshipExample Related Claim Relationship Codesactive1fm2024-04uvhl7tho
hl7.terminologyR5ex-revenue-centerExample Revenue Center Codesactive1fm2024-04uvhl7tho
hl7.terminologyR5fundsreserveFunds Reservation Codesactive1fm2024-04uvhl7tho
us.nlm.vsacR42.16.840.1.113762.1.4.1111.146Buprenorphineactive2022-03ushl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1111.166Codeine Schedule II and IIIactive2023-03ushl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1111.167Alfentanilactive2021-02ushl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1111.168Remifentanilactive2021-02ushl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1111.169Sufentanilactive2021-02ushl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1125.1Schedule IV Benzodiazepinesactive2025-02ushl7rx
us.nlm.vsacR42.16.840.1.113883.3.3157.1002.11Oxycodoneactive2023-03ushl7rx
us.nlm.vsacR42.16.840.1.113883.3.3157.1002.12Oxymorphoneactive2022-03ushl7rx
us.nlm.vsacR42.16.840.1.113883.3.3157.1002.70Morphineactive2024-02ushl7rx
us.nlm.vsacR42.16.840.1.113883.3.3157.1002.71Methadone Medicationsactive2021-02ushl7rx
us.nlm.vsacR42.16.840.1.113883.3.3157.1002.72Meperidineactive2024-02ushl7rx
us.nlm.vsacR42.16.840.1.113883.3.3157.1002.73Levorphanolactive2021-02ushl7rx
us.nlm.vsacR42.16.840.1.113883.3.3157.1002.74Hydromorphoneactive2021-02ushl7rx
us.nlm.vsacR42.16.840.1.113883.3.3157.1002.75Hydrocodoneactive2025-02ushl7rx
us.nlm.vsacR42.16.840.1.113883.3.3157.1002.76Fentanylactive2024-02ushl7rx
us.nlm.vsacR42.16.840.1.113883.3.3157.1004.12Butorphanolactive2021-02ushl7rx
us.nlm.vsacR42.16.840.1.113883.3.3157.1004.15Opium Combinationsactive2024-02ushl7rx
us.nlm.vsacR42.16.840.1.113883.3.3157.1004.16Pentazocineactive2024-02ushl7rx
us.nlm.vsacR42.16.840.1.113883.3.3157.1004.17Tapentadolactive2021-02ushl7rx
us.nlm.vsacR42.16.840.1.113883.3.3157.1004.18Tramadolactive2024-02ushl7rx
hl7.terminologyR5adjudication-reasonAdjudication Reason Codesactive1fm2024-04uvhl7tho
hl7.terminologyR5payment-adjustment-reasonPayment Adjustment Reason Codesactive1fm2024-04uvhl7tho
hl7.fhir.us.mihrR4hypertensive-disorders-pregnancy-ICDValueSet – Hypertensive Disorders of Pregnancy ICDdraft2023-03ushl7icd
hl7.fhir.us.mihrR4hypertensive-disorders-pregnancy-SNOMEDValueSet – Hypertensive Disorders of Pregnancy SNOMED CTdraft2023-03ushl7sct
ch.fhir.ig.swissnosoR4swissnoso-specialtySwissnoso Specialtyactive2022-06chhl7internal
ch.fhir.ig.swissnosoR4swissnoso-organizational-unitSwissnoso Organizational Unitactive2022-06chhl7internal
ch.fhir.ig.swissnosoR4swissnoso-germSwissnoso Germactive2022-06chhl7sct
hl7.fhir.us.eltssR4eltss-observation-codeObservation Code Value Setinformativehsswg2019-09ushl7fhir loinc
us.nlm.vsacR42.16.840.1.113883.11.20.9.69.6Planned or Completed moodCodeactive2024-06ushl7tho
ch.fhir.ig.swissnosoR4swissnoso-bacterial-count-in-urineSwissnoso Bacterial Count in Urineactive2022-06chhl7internal
ch.fhir.ig.swissnosoR4swissnoso-clinical-symptomSwissnoso Clinical Symptomactive2022-06chhl7internal
ch.fhir.ig.swissnosoR4swissnoso-indicationSwissnoso Indicationactive2022-06chhl7internal
ch.fhir.ig.swissnosoR4swissnoso-number-of-different-germsSwissnoso Number of Different Germsactive2022-06chhl7internal
ch.fhir.ig.swissnosoR4swissnoso-procedure-locationSwissnoso Procedure Locationactive2022-06chhl7internal
HIE2.packagesR4targetDiseases-uv-ipsVaccine Target Diseases - IPSactive2022-01uvhl7sct
ca.infoway.vc.psR4CVC-GenericCanadian Vaccine Catalogue Vaccine Generic Namesdraft2021-11canational
ca.infoway.vc.psR4CVC-TradenameCanadian Vaccine Catalogue Vaccine Tradenamesdraft2021-11canational
HIE2.packagesR4targetDiseases-gps-uv-ipsVaccine Target Diseases (GPS) - IPSactive2022-01uvhl7sct
HIE2.packagesR4vaccines-gps-uv-ipsVaccines (GPS) - IPSactive2022-01uvhl7sct
hl7.terminologyR5benefit-networkNetwork Type Codesactive1fm2025-05uvhl7tho
us.cdc.phinvadsR42.16.840.1.114222.4.11.7664Data Elements (NND Babesiosis)active2018-01ussct oid loinc
us.cdc.phinvadsR42.16.840.1.114222.4.11.7811Data Elements (CRS)active2018-01usoid loinc
us.cdc.phinvadsR42.16.840.1.114222.4.11.7525Data Elements (NND CS)active2018-01usoid loinc
us.cdc.phinvadsR42.16.840.1.114222.4.11.7663Data Elements (NND Malaria)active2018-01ussct oid loinc
us.cdc.phinvadsR42.16.840.1.114222.4.11.7816Data Elements (Rubella)active2018-01ussct oid loinc
us.cdc.phinvadsR42.16.840.1.114222.4.11.7665Data Elements (NND Varicella)active2018-01ussct oid loinc
hl7.terminologyR5process-priorityProcess Priority Codesactive1fm2024-04uvhl7tho
hl7.terminologyR5consent-scopeConsent Scope Codesactive2cbcc2024-04uvhl7tho
hl7.fhir.be.medicationR4BeMedicationLineRegistrationStatusVSMedication Line Registration Status Value Setdraft2025-07behl7
ihe.pcc.mapsR4Antepartum.Family.History.and.Genetic.Screening.VSAntepartum Family History and Genetic Screeningactive2024-10uvihesct
hl7.fhir.us.pacio-tocR4toc-loinc-answered-by-LL5571-6-vsTransitions of Care LOINC Terms Answered by LL5571-6 Answer List Value Settrial-use2pc2025-06ushl7loinc
hl7.fhir.us.pacio-tocR4toc-del-loinc-vsTransitions of Care DEL LOINC Terms Value Settrial-use2pc2025-06ushl7loinc
hl7.fhir.us.pacio-tocR4toc-del-loinc-answered-by-LL5571-6-vsTransitions of Care LOINC Terms Included in the DEL Answered by LL5571-6 Answer List Value Settrial-use2pc2025-06ushl7fhir
hl7.terminologyR5medical-management-typeMedical Management Typeactive1fm2025-05uvhl7tho
hl7.eu.fhir.idea4rcR4disease-extent-category-vsSarcoma Staging: localized diseasedraft2025-07euhl7
hl7.eu.fhir.idea4rcR4locoregional-category-vsStaging: loco-regional categorydraft2025-07euhl7
hl7.fhir.uv.cqmR4subject-typeSubject Type Value Settrial-use4cqi2024-08uvhl7fhir
ca.on.oh.mha.pdsR4confirmed-diagnosisConfirmed Diagnosisdraftfhir
fi.digious.kanta.testR4fiphr-vs-fitnessresultValue Set Finnish PHR Fitness Resultsactive02018-12loinc
fi.digious.kanta.testR4fiphr-vs-vitalsignsValue Set Finnish PHR Vital Signsactive2020-04loinc
us.cdc.phinvadsR42.16.840.1.113883.11.20.9.38Current Smoking Status (NAACCR)active2015-01ussct
hl7.fhir.uv.ipsR4problem-type-loincProblem Type (LOINC)trial-use2pc2025-08uvhl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1099.28Problem Type (LOINC)active2023-07ushl7loinc
ca.on.oh.mha.pdsR4opioid-agonist-medicationOpioid Agonist Medicationdraftcanational
us.nlm.vsacR42.16.840.1.113883.11.20.9.39Result Statusactive2024-06ushl7tho
us.nlm.vsacR42.16.840.1.113762.1.4.1078.476Allergy To Vaccine Componentactive2023-07ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1115.2InstructionActStatusactive2017-11ushl7tho
us.nlm.vsacR42.16.840.1.113883.11.20.9.69.7Obligation or Prohibition Instruction Typeactive2017-11ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1096.58Findings Related to Medication Management, Chronic Disease Presentactive2023-12ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1096.59Findings Related to Medication Management, Taking Medication for Chronic Diseaseactive2017-08ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1219.150Fall or Fall Risk from Wheelchair or Scooter ICD10CMactive2022-03ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1219.147Mobility Impairment or Fall From Chair ICD10CMactive2022-03ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1219.144Bed Confinement Impairmentactive2022-03ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1032.302Test Cervical Excision Proceduresactive2023-10ushl7sct
HIE2.packagesR4core-problem-finding-situation-event-gps-uv-ipsCORE Problem List Finding/Situation/Event (GPS) - IPSactive2022-01uvhl7sct
hl7.fhir.uv.ebmR6179431EvidenceReportSectionCode Value Setactive2025-08uvhl7
us.cdc.phinvadsR42.16.840.1.114222.4.11.7449Qualitative Lab Result (RCMT)active2016-01ussct
hl7.fhir.us.coreR4us-core-screening-assessment-observation-maximum-categoryUS Core Screening Assessment Observation Maximum Categorytrial-use3cgp2024-11ushl7fhir tho
hl7.fhir.us.coreR4us-core-simple-observation-categoryUS Core Simple Observation Categorytrial-use3cgp2024-11ushl7fhir tho
us.nlm.vsacR42.16.840.1.113883.11.20.9.87Postpartum Statusactive2024-06ushl7sct
us.nlm.vsacR42.16.840.1.113883.3.3157.190123Diagnostic Mammography Studyactive2018-04ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.3157.1902Ultrasound of the Breastactive2019-01ushl7cpt
us.nlm.vsacR42.16.840.1.113883.3.3157.190412Screening Mammography and DBT Studiesactive2018-04ushl7vsac
us.nlm.vsacR42.16.840.1.113883.3.3157.4066Diagnostic DBT Studyactive2022-05ushl7vsac
us.nlm.vsacR42.16.840.1.13883.3.3157.4067MRI of the Breastactive2024-06ushl7cms
us.nlm.vsacR42.16.840.1.13883.3.3157.4068MRI of the Breastactive2022-05ushl7vsac
poc.bonsai.currentR4dispensing-restrictionsUtlämnandebegränsningactive2022-02
poc.bonsai.currentR4narcotic-classificationNarkotikaklassactive2022-02
poc.bonsai.currentR4product-typesProdukttypactive2022-03
us.nlm.vsacR42.16.840.1.113762.1.4.1267.25Detailed race including absence reasons.active2025-04ushl7vsac
us.cdc.phinvadsR42.16.840.1.114222.4.11.6066Ethnic Group (HL7)active2012-01ustho
us.nlm.vsacR42.16.840.1.113762.1.4.1115.6Personal Health Goals LOINCactive2024-07ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1115.13Healthcare Agent Powers or Limitations Indicatoractive2024-11ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1221.208Sexual Orientationactive2024-04ushl7sct
ca.on.ehr.r4R4ValueSet-ErrorCodeError Code EHRactive2025-01canational
us.nlm.vsacR42.16.840.1.113762.1.4.1032.264CDS Pregnancyactive2024-06ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1032.265CDS Pregnancy Intensionalactive2024-06ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1032.11Cirrhosis ICD9CMactive2024-06ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1032.13Cirrhosis SNOMEDCTactive2024-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1032.14Cirrhosisactive2024-06ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1221.179Abortion Medicationsactive2024-04ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1221.184Letrozole (Aromatase inhibitor)active2024-04ushl7rx
hl7.fhir.uv.genomics-reportingR4molecular-biomarker-category-vsMolecular Biomarker Categoriesinformativecg2025-06uvhl7fhir
us.nlm.vsacR42.16.840.1.113762.1.4.1260.12Negativeactive2023-08ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1095.11Nutrition Focused Physical Findings SNOMED CTactive2025-01ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1096.207PharmacyEnvironmentsOfCareactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1096.205PharmacyTypeOfProfessionactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1096.181PharmacyEncounterReasonactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1096.197PharmacyAllergiesactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1096.198PharmacyInterventionsactive2024-03ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1096.200PharmacyReasonsForInterventionsactive2024-03ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1096.201PharmacyInterventionStatusactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1096.202PharmacyCareCoordinationactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1096.203PharmacyReferralsToactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1096.204PharmacyGoalStatusOutcomeactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1096.208PharmacyEncounterTypeactive2022-03ushl7vsac